Davide Leone & Partners Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,433,400	Closed	-$79.3M	–	11
2018 Q2	$79.3M	Buy	1,433,400 +190,000	+15%	+$10.3M	7.03%	6
2018 Q1	$78.6M	Buy	1,243,400 +1,118,400	+895%	+$71.9M	5.74%	9
2017 Q4	$7.66M	Hold	125,000	–	–	0.49%	28
2017 Q3	$7.97M	Buy	+125,000	New	+$7.3M	0.71%	17
2017 Q2	–	Sell	-1,385,000	Closed	-$75.4M	–	18
2017 Q1	$75.3M	Buy	1,385,000 +290,000	+26%	+$15.9M	7.48%	6
2016 Q4	$64M	Buy	1,095,000 +600,000	+121%	+$32.8M	7.67%	6
2016 Q3	$26.7M	Buy	+495,000	New	+$31.8M	2.6%	12
2015 Q1	–	Sell	-191,833	Closed	-$11.3M	–	20
2014 Q4	$11.3M	Buy	+191,833	New	+$10.8M	0.93%	19
2014 Q3	–	Sell	-183,000	Closed	-$8.88M	–	22
2014 Q2	$8.88M	Buy	+183,000	New	+$9.02M	1.81%	11

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Davide Leone & Partners Investment Company's BMY Position: Q3 2018 in Review

Davide Leone & Partners Investment Company sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 1,433,400 shares — an estimated $79.3M sold.

Davide Leone & Partners Investment Company first reported a position in BMY in Q2 2014 and held it in 9 quarters. The position peaked at $79.3M in Q2 2018. 1,730 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

Davide Leone & Partners Investment Company reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
Davide Leone & Partners Investment Company sold 1,433,400 Bristol-Myers Squibb shares in Q3 2018, an estimated $79.3M.
Davide Leone & Partners Investment Company first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 9 quarters.
Davide Leone & Partners Investment Company's Bristol-Myers Squibb position peaked at $79.3M in Q2 2018.
1,730 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Davide Leone & Partners Investment Company's 13F filing for Q3 2018, filed 14 Nov 2018.